---
document_datetime: 2023-09-21 17:28:51
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/cervarix-epar-all-authorised-presentations_en.pdf
document_name: cervarix-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.7421571
conversion_datetime: 2025-12-22 16:42:38.85831
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical form      | Route of administration   | Immediate Packaging        | Content (concentration)   | Pack size                           |
|------------------|-------------------|------------|--------------------------|---------------------------|----------------------------|---------------------------|-------------------------------------|
| EU/1/07/419/001  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | vial (glass)               | 0.5 ml                    | 1 vial                              |
| EU/1/07/419/002  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | vial (glass)               | 0.5 ml                    | 10 vials                            |
| EU/1/07/419/003  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | vial (glass)               | 0.5 ml                    | 100 vials                           |
| EU/1/07/419/004  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe + 1 needle     |
| EU/1/07/419/005  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe + 2 needles    |
| EU/1/07/419/006  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes + 10 needles |
| EU/1/07/419/007  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes + 20 needles |
| EU/1/07/419/008  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 1 pre-filled syringe                |
| EU/1/07/419/009  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | pre-filled syringe (glass) | 0.5 ml                    | 10 pre-filled syringes              |
| EU/1/07/419/010  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | vial (glass)               | 1 ml                      | 1 vial (multidose)                  |
| EU/1/07/419/011  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | vial (glass)               | 1 ml                      | 10 vials (multidose)                |
| EU/1/07/419/012  | Cervarix          | -- 1       | Suspension for injection | Intramuscular use         | vial (glass)               | 1 ml                      | 100 vials (multidose)               |

## --1 1 dose (0.5 ml) contains: Human Papillomavirus 1  type 16 L1 protein 2,3,4 20 micrograms Human Papillomavirus 1  type 18 L1 protein 2,3,4 20 micrograms

1 Human Papillomavirus = HPV 2 adjuvanted by AS04 containing: 3-O-desacyl-4'- monophosphoryl lipid A (MPL) 3 50 micrograms 3 adsorbed on aluminium hydroxide, hydrated (Al(OH)3) 0.5 milligrams Al 3+ in total 4

L1 protein in the form of non-infectious virus-like particles (VLPs) produced by recombinant DNA technology using a Baculovirus expression system which uses Hi-5 Rix4446 cells derived from Trichoplusia ni .